During the past decade, Vanak Eye Surgery Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vanak Eye Surgery Center" are "Refractory Glaucoma" (2 trials) and "Refractory Primary Open Angle Glaucoma" (1 trials). Many other conditions were trialed in "Vanak Eye Surgery Center" in a lesser frequency.

Most popular intervention types in "Vanak Eye Surgery Center" are "Device" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ahmed Valve implant" (1 trials), "Ahmed valve implant" (1 trials), "Implantation of Ahmed glaucoma tube shunt, and Trabeculectomy with MMC" (1 trials), "Molteno single-plate implant (MSPI)" (1 trials) and "Subconjunctival Avastin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vanak Eye Surgery Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Vanak Eye Surgery Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vanak Eye Surgery Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vanak Eye Surgery Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".